5 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman

Page 1 of 5

In this article, we discuss the 5 best pharmaceutical stocks to buy according to billionaire Joseph Edelman. If you want to read our detailed analysis of Edelman’s history and hedge fund performance, go directly to the 10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman.

5. Agile Therapeutics, Inc. (NASDAQ: AGRX)

Edelman’s Stake Value: $33,113,000
Percentage of Joseph Edelman’s 13F Portfolio: 0.41%
Number of Hedge Fund Holders: 6

Agile Therapeutics, Inc. (NASDAQ: AGRX) an American women’s healthcare company, which experiments, develops, and commercializes prescription contraceptive products for women. The company was incorporated in 1997 and stands fifth on the list of 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman. Agile Therapeutics currently has a $118.27 million market capitalization. 

On May 4, Agile Therapeutics, Inc. (NASDAQ: AGRX) declared quarterly earnings per share of -$0.20 beating the estimates by $0.01. In April, the stock was rated as “Outperform” at RBC Capital, where the price target was set at $8.00.

Perceptive Advisors holds 15.92 million shares of the company, worth $33.11 million. In the first quarter of 2021, 6 hedge funds in the database of Insider Monkey held stakes worth $35.25 million in Agile Therapeutics, Inc. (NASDAQ: AGRX), down from 8 the preceding quarter worth $48.21 million.



Page 1 of 5